Evidence map›Paper›PMID 20087754›Full record

ArticleJournal of neuro-oncology2010

Germinomas in the basal ganglia: magnetic resonance imaging classification and the prognosis.

Ji Hoon Phi, Byung-Kyu Cho, Seung-Ki Kim, Jin Chul Paeng, In-One Kim, Il Han Kim, Dong Gyu Kim, Hee-Won Jung, Jeong Eun Kim, Kyu-Chang Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. [Clinical analysis of 30 cases of basal ganglia germinoma in children].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. A single-center study of treatment outcomes of pediatric basal ganglia germinoma in Taiwan.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Intracranial Germ Cell Tumor in the Molecular Era.Journal of Korean Neurosurgical Society · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Germinoma in the bilateral basal ganglia presented with cognitive deterioration.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 3 countries.

Ji Hoon PhiDepartment of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehangno, Jongno-gu, Seoul 110-744, Republic of Korea.
Byung-Kyu Cho
Seung-Ki Kim
Jin Chul Paeng
In-One Kim
Il Han Kim
Dong Gyu Kim
Hee-Won Jung
Jeong Eun Kim
Kyu-Chang Wang
Seoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germinoma in the basal ganglia (BG) is notorious for its diagnostic difficulty. Clinical and radiological features of this disease are quite diverse, but have not been well characterized with respect to prognosis. We retrospectively reviewed the clinical course and treatment outcomes of 17 patients with a BG germinoma. The initial magnetic resonance imaging (MRI) features were classified. Clinical features and treatment outcomes were then analyzed with this classification scheme. A Type 1 lesion was defined as a subtle lesion with faint or no contrast enhancement (six patients). Type 2, 3, and 4 lesions were defined as contrast-enhancing lesions and were differentiated by the lesion size and the presence of subependymal seeding (11 patients). Type 1 lesions were distinct from the other lesions. Patients with a Type 1 lesion had a significantly longer time from the initial MRI to diagnosis than patients with Type 2, 3, and 4 lesions (P = 0.012). The actuarial progression-free survival and overall survival of patients 5 years after diagnosis were 66 and 77%, respectively. The presence of a Type 1 lesion (P = 0.004), a longer time delay in the diagnosis (P = 0.038), and radiation therapy without complete ventricular coverage (P = 0.010) were significantly associated with tumor progression. Profound motor deficits at diagnosis were associated with deterioration in motor function after tumor remission (P = 0.035). Early diagnosis of BG germinomas could affect the ability to control a tumor and neurological outcomes. In particular, high clinical suspicion and active diagnostic procedures are recommended. For optimal treatment, radiation fields should include entire ventricles even if there is no subependymal seeding.

Indexed as

Magnetic Resonance ImagingAdolescentAdultBasal Ganglia DiseasesBrain NeoplasmsChildCombined Modality TherapyFemaleFollow-Up StudiesGerminomaHumansMaleNeoplasm StagingPositron-Emission TomographySurvival RateTreatment Outcome

Identifiers

PMID20087754
OpenAlexW2076081257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.